239 related articles for article (PubMed ID: 8851568)
1. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Barbara-Burnham L; Young LS
Antimicrob Agents Chemother; 1996 Mar; 40(3):546-51. PubMed ID: 8851568
[TBL] [Abstract][Full Text] [Related]
2. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
Kohno Y; Ohno H; Miyazaki Y; Higashiyama Y; Yanagihara K; Hirakata Y; Fukushima K; Kohno S
Antimicrob Agents Chemother; 2007 Nov; 51(11):4071-6. PubMed ID: 17709469
[TBL] [Abstract][Full Text] [Related]
4. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
[TBL] [Abstract][Full Text] [Related]
5. In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.
Hoffner SE; Kratz M; Olsson-Liljequist B; Svenson SB; Källenius G
J Antimicrob Chemother; 1989 Sep; 24(3):317-24. PubMed ID: 2808189
[TBL] [Abstract][Full Text] [Related]
6. Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.
Bermudez LE; Kolonoski P; Young LS
Antimicrob Agents Chemother; 1996 Apr; 40(4):1033-5. PubMed ID: 8849223
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
Sato K; Tomioka H; Akaki T; Kawahara S
Int J Antimicrob Agents; 2000 Sep; 16(1):25-9. PubMed ID: 11185410
[TBL] [Abstract][Full Text] [Related]
8. In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex.
Gevaudan MJ; Bollet C; Mallet MN; de Micco P
J Antimicrob Chemother; 1993 May; 31(5):725-30. PubMed ID: 8392998
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
Rastogi N; Goh KS; Bryskier A; Devallois A
Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
[TBL] [Abstract][Full Text] [Related]
10. Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.
Bermudez LE; Kolonoski P; Wu M; Aralar PA; Inderlied CB; Young LS
Antimicrob Agents Chemother; 1999 Aug; 43(8):1870-4. PubMed ID: 10428905
[TBL] [Abstract][Full Text] [Related]
11. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.
Bermudez LE; Kolonoski P; Petrofsky M; Wu M; Inderlied CB; Young LS
J Infect Dis; 2003 Jun; 187(12):1977-80. PubMed ID: 12792877
[TBL] [Abstract][Full Text] [Related]
12. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Tomioka H; Sato K; Kajitani H; Akaki T; Shishido S
Antimicrob Agents Chemother; 2000 Feb; 44(2):283-6. PubMed ID: 10639351
[TBL] [Abstract][Full Text] [Related]
13. Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.
Bermudez LE; Nash K; Petrofsky M; Young LS; Inderlied CB
Antimicrob Agents Chemother; 2000 Oct; 44(10):2619-22. PubMed ID: 10991834
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
Yajko DM; Sanders CA; Nassos PS; Hadley WK
Antimicrob Agents Chemother; 1990 Dec; 34(12):2442-4. PubMed ID: 2088204
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex.
Tomioka H; Sano C; Sato K; Shimizu T
Int J Antimicrob Agents; 2002 Feb; 19(2):139-45. PubMed ID: 11850167
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Tomioka H; Sato K; Akaki T; Kajitani H; Kawahara S; Sakatani M
Antimicrob Agents Chemother; 1999 Dec; 43(12):3001-4. PubMed ID: 10582897
[TBL] [Abstract][Full Text] [Related]
17. Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.
Bermudez LE; Nash KA; Petrofsky M; Young LS; Inderlied CB
J Infect Dis; 1996 Dec; 174(6):1218-22. PubMed ID: 8940212
[TBL] [Abstract][Full Text] [Related]
18. Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
Klemens SP; DeStefano MS; Cynamon MH
Antimicrob Agents Chemother; 1992 Nov; 36(11):2413-7. PubMed ID: 1336945
[TBL] [Abstract][Full Text] [Related]
19. Comparative in-vitro activity of Bay y 3118, a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Sirgel FA; Venter A; Heilmann HD
J Antimicrob Chemother; 1995 Feb; 35(2):349-51. PubMed ID: 7759400
[No Abstract] [Full Text] [Related]
20. Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.
Bermudez LE; Kolonoski P; Young LS; Inderlied CB
Antimicrob Agents Chemother; 1994 Aug; 38(8):1844-8. PubMed ID: 7986018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
